World Top 100 Biotechnology Companies List by Market Cap as of August 2026

World Top 100 Biotechnology Companies List by Market Cap as of August 2026, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as of August 2026.

World Top Biotechnology Companies in 2026
World Largest Biotechnology Companies by Market Cap in 2026, World Top Biotechnology Companies by Market Cap in 2026.

  1. Tibet Cheezheng Tibetan Medicine

    World Rank (Aug-2026)
    7,017
    Market Cap (Aug-2026)
    1.675 Billion USD
    World Rank (Jan-05-2024)
    6,356
    Market Cap (Jan-05-2024)
    1.659 Billion USD
    World Rank (Jul-30-2023)
    6,165
    Market Cap (Jul-30-2023)
    1.785 Billion USD
    World Rank (Dec-25-2022)
    5,959
    Market Cap (Dec-25-2022)
    1.732 Billion USD
    World Rank (Jan-07-2022)
    5,465
    Market Cap (Jan-07-2022)
    2.51 Billion USD
    Annual Revenue in USD
    258 Million USD
    Annual Net Income in USD
    104 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    China
    Yahoo @ Shenzhen
    Company Website
    TIBET CHEEZHENG TIBETAN MEDICINE

  2. Intellia Therapeutics

    World Rank (Aug-2026)
    7,030
    Market Cap (Aug-2026)
    1.669 Billion USD
    World Rank (Jan-05-2024)
    4,779
    Market Cap (Jan-05-2024)
    2.644 Billion USD
    World Rank (Jul-30-2023)
    3,722
    Market Cap (Jul-30-2023)
    3.734 Billion USD
    World Rank (Dec-25-2022)
    4,066
    Market Cap (Dec-25-2022)
    3.016 Billion USD
    World Rank (Jan-07-2022)
    2,284
    Market Cap (Jan-07-2022)
    7.87 Billion USD
    Annual Revenue in USD
    68 Million USD
    Annual Operating Income in USD
    -441 Million USD
    Annual Net Income in USD
    -413 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Intellia Therapeutics is a Biotechnology company. The company annual revenue is 43.2 million USD, total assets is 334.2 million USD and 211 employees as on 2019. The headquarters is in USA.

    Company Website
    INTELLIA THERAPEUTICS
    Wikipedia
    Wikipedia

  3. Immunocore Holdings PLC

    World Rank (Aug-2026)
    7,095
    Market Cap (Aug-2026)
    1.645 Billion USD
    World Rank (Jan-05-2024)
    4,182
    Market Cap (Jan-05-2024)
    3.200 Billion USD
    World Rank (Jul-30-2023)
    4,317
    Market Cap (Jul-30-2023)
    3.041 Billion USD
    World Rank (Dec-25-2022)
    4,355
    Market Cap (Dec-25-2022)
    2.769 Billion USD
    World Rank (Jan-07-2022)
    8,234
    Market Cap (Jan-07-2022)
    1.26 Billion USD
    Annual Revenue in USD
    31 Million USD
    Annual Net Income in USD
    -154 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    UK
    Stock Category
    UK ADRs
    Yahoo @ Nasdaq
    Company Profile

    Immunocore is a pioneering, clinical-stage T cell receptor biotechnology company working to develop and commercialize a new generation of transformative medicines to address unmet needs in cancer, infection and autoimmune disease. Headquarters is in UK.

    Company Website
    IMMUNOCORE HOLDINGS PLC

  4. Inner Mongolia Furui Medical Science

    World Rank (Aug-2026)
    7,113
    Market Cap (Aug-2026)
    1.637 Billion USD
    World Rank (Jan-05-2024)
    6,668
    Market Cap (Jan-05-2024)
    1.538 Billion USD
    World Rank (Jul-30-2023)
    9,710
    Market Cap (Jul-30-2023)
    0.831 Billion USD
    World Rank (Dec-25-2022)
    8,994
    Market Cap (Dec-25-2022)
    0.888 Billion USD
    World Rank (Jan-07-2022)
    12,660
    Market Cap (Jan-07-2022)
    0.57 Billion USD
    Headquarters Country
    China
    Yahoo @ Shenzhen
    Company Website
    INNER MONGOLIA FURUI MEDICAL SCIENCE

  5. Forte Biosciences Inc.

    World Rank (Aug-2026)
    7,130
    Market Cap (Aug-2026)
    1.631 Billion USD
    World Rank (Jan-05-2024)
    27,186
    Market Cap (Jan-05-2024)
    0.030 Billion USD
    World Rank (Jul-30-2023)
    29,222
    Market Cap (Jul-30-2023)
    0.021 Billion USD
    World Rank (Dec-25-2022)
    29,143
    Market Cap (Dec-25-2022)
    0.021 Billion USD
    World Rank (Jan-07-2022)
    28,669
    Market Cap (Jan-07-2022)
    0.03 Billion USD
    Annual Operating Income in USD
    -71 Million USD
    Annual Net Income in USD
    -69 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Profile
    Forte Biosciences, Inc. is a clinical stage biopharmaceutical company focused on dermatology. The company total assets are 61.2 million USD a son 2020. The headquarters is in USA.
    Company Website
    FORTE BIOSCIENCES, INC.

  6. Chengzhi Shareholding

    World Rank (Aug-2026)
    7,170
    Market Cap (Aug-2026)
    1.617 Billion USD
    World Rank (Jan-05-2024)
    6,910
    Market Cap (Jan-05-2024)
    1.449 Billion USD
    World Rank (Jul-30-2023)
    7,189
    Market Cap (Jul-30-2023)
    1.396 Billion USD
    World Rank (Dec-25-2022)
    6,564
    Market Cap (Dec-25-2022)
    1.498 Billion USD
    World Rank (Jan-07-2022)
    4,826
    Market Cap (Jan-07-2022)
    3.02 Billion USD
    Annual Revenue in USD
    1,773 Million USD
    Annual Net Income in USD
    147 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    China
    Yahoo @ Shenzhen
    Company Website
    CHENGZHI SHAREHOLDING

  7. Eton Pharmaceuticals

    World Rank (Aug-2026)
    7,186
    Market Cap (Aug-2026)
    1.612 Billion USD
    World Rank (Jan-05-2024)
    20,540
    Market Cap (Jan-05-2024)
    0.119 Billion USD
    World Rank (Jul-30-2023)
    23,863
    Market Cap (Jul-30-2023)
    0.065 Billion USD
    World Rank (Dec-25-2022)
    22,978
    Market Cap (Dec-25-2022)
    0.077 Billion USD
    World Rank (Jan-07-2022)
    22,295
    Market Cap (Jan-07-2022)
    0.11 Billion USD
    Annual Revenue in USD
    80 Million USD
    Annual Operating Income in USD
    -1 Million USD
    Annual Net Income in USD
    -5 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Website
    ETON PHARMACEUTICALS

  8. Ascentage Pharma Group International

    World Rank (Aug-2026)
    7,222
    Market Cap (Aug-2026)
    1.592 Billion USD
    World Rank (Jan-05-2024)
    8,722
    Market Cap (Jan-05-2024)
    0.974 Billion USD
    World Rank (Jul-30-2023)
    9,466
    Market Cap (Jul-30-2023)
    0.867 Billion USD
    World Rank (Dec-25-2022)
    9,295
    Market Cap (Dec-25-2022)
    0.845 Billion USD
    World Rank (Jan-07-2022)
    10,228
    Market Cap (Jan-07-2022)
    0.86 Billion USD
    Headquarters Country
    China
    Yahoo @ HongKong
    Company Website
    ASCENTAGE PHARMA GROUP INTERNATIONAL

  9. Absci Corp

    World Rank (Aug-2026)
    7,267
    Market Cap (Aug-2026)
    1.575 Billion USD
    World Rank (Jan-05-2024)
    14,874
    Market Cap (Jan-05-2024)
    0.346 Billion USD
    World Rank (Jul-30-2023)
    18,130
    Market Cap (Jul-30-2023)
    0.197 Billion USD
    World Rank (Dec-25-2022)
    18,001
    Market Cap (Dec-25-2022)
    0.200 Billion USD
    World Rank (Jan-07-2022)
    11,637
    Market Cap (Jan-07-2022)
    0.67 Billion USD
    Annual Revenue in USD
    3 Million USD
    Annual Operating Income in USD
    -120 Million USD
    Annual Net Income in USD
    -115 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Website
    ABSCI CORP

  10. Xeris Pharmaceuticals

    World Rank (Aug-2026)
    7,279
    Market Cap (Aug-2026)
    1.568 Billion USD
    World Rank (Jan-05-2024)
    14,821
    Market Cap (Jan-05-2024)
    0.349 Billion USD
    World Rank (Jul-30-2023)
    15,032
    Market Cap (Jul-30-2023)
    0.347 Billion USD
    World Rank (Dec-25-2022)
    18,889
    Market Cap (Dec-25-2022)
    0.171 Billion USD
    World Rank (Jan-07-2022)
    16,375
    Market Cap (Jan-07-2022)
    0.32 Billion USD
    Annual Revenue in USD
    292 Million USD
    Annual Operating Income in USD
    25 Million USD
    Annual Net Income in USD
    1 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Website
    XERIS PHARMACEUTICALS

Share